| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.14 | 0.0007 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.001 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.003 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.004 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.005 |